Evidence map›Paper›PMID 30988608›Full record

ArticleInternational journal of nanomedicine2019

Plasma protein adsorption on Fe

V Escamilla-Rivera, A Solorio-Rodríguez, M Uribe-Ramírez, O Lozano, S Lucas, A Chagolla-López, R Winkler, A De Vizcaya-Ruiz

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Magneto-Mechanical Actuation Induces Endothelial Permeability.ACS biomaterials science & engineering · 2023
    Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Frontiers in bioengineering and biotechnology · 2021
    Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

V Escamilla-RiveraDepartamento de Toxicología, Centro de Investigación y de Estudios Avanzados del IPN (CINVESTAV-IPN), Ciudad de México, México, avizcaya@cinvestav.mx.
A Solorio-RodríguezDepartamento de Toxicología, Centro de Investigación y de Estudios Avanzados del IPN (CINVESTAV-IPN), Ciudad de México, México, avizcaya@cinvestav.mx.
M Uribe-RamírezDepartamento de Toxicología, Centro de Investigación y de Estudios Avanzados del IPN (CINVESTAV-IPN), Ciudad de México, México, avizcaya@cinvestav.mx.
O LozanoNamur Nanosafety Centre, Namur Research Institute for Life Sciences, University of Namur, Namur, Belgium.
S LucasNamur Nanosafety Centre, Namur Research Institute for Life Sciences, University of Namur, Namur, Belgium.
A Chagolla-LópezDepartmento de Biotecnología y Bioquímica, CINVESTAV-IPN, Unidad Irapuato, Irapuato, México.
R WinklerDepartmento de Biotecnología y Bioquímica, CINVESTAV-IPN, Unidad Irapuato, Irapuato, México.
A De Vizcaya-RuizDepartamento de Toxicología, Centro de Investigación y de Estudios Avanzados del IPN (CINVESTAV-IPN), Ciudad de México, México, avizcaya@cinvestav.mx.
Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional · MXInstituto Tecnológico Superior de Irapuato · MXUniversity of Namur · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUnderstanding of iron oxide nanoparticles (IONP) interaction with the body milieu is crucial to guarantee their efficiency and biocompatibility in nanomedicine. Polymer coating to IONP, with polyethyleneglycol (PEG) and polyvinylpyrrolidone (PVP), is an accepted strategy to prevent toxicity and excessive protein binding.

aimThe aim of this study was to investigate the feature of IONP adsorption of complement proteins, their activation and consequent inflammatory response as a strategy to further elucidate their biocompatibility.

methodsThree types of IONP with different surface characteristics were used: bare (IONP-bare), coated with PVP (IONP-PVP) and PEG-coated (IONP-PEG). IONPs were incubated with human plasma and adsorbed proteins were identified. BALB/c mice were intravenously exposed to IONP to evaluate complement activation and proinflammatory response.

resultsProtein corona fingerprinting showed that PEG surface around IONP promoted a selective adsorption of complement recognition molecules which would be responsible for the complement system activation. Furthermore, IONP-PEG activated in vitro, the complement system and induced a substantial increment of C3a and C4a anaphylatoxins while IONP-bare and IONP-PVP did not. In vivo IONP-PEG induced an increment in complement activation markers (C5a and C5b-9), and proinflammatory cytokines (IL-1β, IL-6, TNF-α).

conclusionThe engineering of nanoparticles must incorporate the association between complement proteins and nanomedicines, which will regulate the immunostimulatory effects through a selective adsorption of plasma proteins and will enable a safer application of IONP in human therapy.

Indexed as

AdsorptionAnaphylatoxinsAnimalsBlood ProteinsComplement ActivationComplement System ProteinsFerric CompoundsHumansInflammationInterleukin-1betaMaleMice, Inbred BALB CNanoparticlesPolyethylene GlycolsPovidoneProtein CoronaAnaphylatoxinsBlood ProteinsComplement System ProteinsFerric Compoundsferric oxideInterleukin-1betaPolyethylene GlycolsPovidoneProtein CoronaTumor Necrosis Factor-alphacomplementinflammatory responseiron oxide nanoparticlesprotein corona

Identifiers

PMID30988608
PMCPMC6438142
OpenAlexW2923736255

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.